当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202029
编号:13797243
术前ALBI分级对肝细胞癌患者术后预后的预测价值的meta分析(4)
http://www.100md.com 2020年10月15日 《中国医药导报》 202029
     [14] Luo HM,Zhao SZ,Li C,et al. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection:A retrospective study [J]. Medicine(Baltimore),2018,97(12):e0226.

    [15] Ma XL,Zhou JY,Gao XH,et al. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma [J]. Clin Chim Acta,2016,462:15-22.

    [16] Toyoda H,Lai PB,O′Beirne J,et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma:application of the ALBI grade [J]. Br J Cancer,2016,114(7):744-750.

    [17] Wang YY,Zhong JH,Su ZY,et al. Albumin-bilirubin versus child-pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma [J]. Br J Surg,2016,103(6):725-734.

    [18] Xu Q,Yan Y,Gu S. A Novel Inflammation-Based Prognostic Score:The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma [J]. J Immunol Res,2018,2018:4925498.

    [19] 中華人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017, 33(8):1419-1431.

    [20] Ba?覦rsak?觭?覦 E,ahin E,Atabey N. Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma [J]. Oncology,2017,93(2):136-142.

    (收稿日期:2020-01-03), http://www.100md.com(罗皓 周静 黄君)
上一页1 2 3 4